JP2015511224A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015511224A5 JP2015511224A5 JP2014554840A JP2014554840A JP2015511224A5 JP 2015511224 A5 JP2015511224 A5 JP 2015511224A5 JP 2014554840 A JP2014554840 A JP 2014554840A JP 2014554840 A JP2014554840 A JP 2014554840A JP 2015511224 A5 JP2015511224 A5 JP 2015511224A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- isochromen
- amino
- pyrazin
- methylpiperazin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 122
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 26
- 125000003282 alkyl amino group Chemical group 0.000 claims 24
- 125000003545 alkoxy group Chemical group 0.000 claims 23
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims 20
- 150000001875 compounds Chemical class 0.000 claims 14
- 125000000623 heterocyclic group Chemical group 0.000 claims 14
- 125000001072 heteroaryl group Chemical group 0.000 claims 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 9
- 208000002320 spinal muscular atrophy Diseases 0.000 claims 7
- 125000003118 aryl group Chemical group 0.000 claims 6
- 229910052736 halogen Inorganic materials 0.000 claims 5
- 150000002367 halogens Chemical class 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- 125000003342 alkenyl group Chemical group 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 210000005260 human cell Anatomy 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims 3
- -1 1,3-dimethylpyrrolo [1,2-a] pyrazin-7-yl Chemical group 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- ZDZWYHMQADVMID-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-(4-propan-2-ylpiperazin-1-yl)isochromen-1-one Chemical compound C1CN(C(C)C)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 ZDZWYHMQADVMID-UHFFFAOYSA-N 0.000 claims 2
- 101000617738 Homo sapiens Survival motor neuron protein Proteins 0.000 claims 2
- 102100021947 Survival motor neuron protein Human genes 0.000 claims 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 125000005241 heteroarylamino group Chemical group 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
- 230000037431 insertion Effects 0.000 claims 2
- 238000003780 insertion Methods 0.000 claims 2
- 108020004999 messenger RNA Proteins 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 1
- SOUNGENGQBGPDJ-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yl)-7-(4-methylpiperazin-1-yl)isochromen-1-one Chemical compound C1CN(C)CCN1C1=CC=C(C=C(OC2=O)C=3C=C4OCOC4=CC=3)C2=C1 SOUNGENGQBGPDJ-UHFFFAOYSA-N 0.000 claims 1
- JCVHRLIRCQUSLG-ZDUSSCGKSA-N 3-(1,3-benzodioxol-5-yl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3C=C4OCOC4=CC=3)C2=C1 JCVHRLIRCQUSLG-ZDUSSCGKSA-N 0.000 claims 1
- XGGJEBZNLNGURJ-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yl)-7-piperazin-1-ylisochromen-1-one Chemical compound C1=C2C(=O)OC(C=3C=C4OCOC4=CC=3)=CC2=CC=C1N1CCNCC1 XGGJEBZNLNGURJ-UHFFFAOYSA-N 0.000 claims 1
- RMMBPLGUTLDIOV-UHFFFAOYSA-N 3-(1,3-benzothiazol-2-yl)-7-(1,4-diazepan-1-yl)isochromen-1-one Chemical compound C1=C2C(=O)OC(C=3SC4=CC=CC=C4N=3)=CC2=CC=C1N1CCCNCC1 RMMBPLGUTLDIOV-UHFFFAOYSA-N 0.000 claims 1
- WLGCJNFSWKPHKI-UHFFFAOYSA-N 3-(1,3-benzothiazol-2-yl)-7-(4-methyl-1,4-diazepan-1-yl)isochromen-1-one Chemical compound C1CN(C)CCCN1C1=CC=C(C=C(OC2=O)C=3SC4=CC=CC=C4N=3)C2=C1 WLGCJNFSWKPHKI-UHFFFAOYSA-N 0.000 claims 1
- JNYYJCBZWIZAQL-ZDUSSCGKSA-N 3-(1,3-benzothiazol-2-yl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3SC4=CC=CC=C4N=3)C2=C1 JNYYJCBZWIZAQL-ZDUSSCGKSA-N 0.000 claims 1
- LFJUHEHZIGVYMZ-OKILXGFUSA-N 3-(1,3-benzothiazol-2-yl)-7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]isochromen-1-one Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3SC4=CC=CC=C4N=3)C2=C1 LFJUHEHZIGVYMZ-OKILXGFUSA-N 0.000 claims 1
- DIDYFUQMYQIJOM-UHFFFAOYSA-N 3-(1,3-benzothiazol-2-yl)-7-piperazin-1-ylisochromen-1-one Chemical compound C1=C2C(=O)OC(C=3SC4=CC=CC=C4N=3)=CC2=CC=C1N1CCNCC1 DIDYFUQMYQIJOM-UHFFFAOYSA-N 0.000 claims 1
- VKOXUCHMDUPJHP-UHFFFAOYSA-N 3-(1,3-dimethylpyrrolo[1,2-a]pyrazin-7-yl)-7-(4-ethylpiperazin-1-yl)isochromen-1-one Chemical compound C1CN(CC)CCN1C1=CC=C(C=C(OC2=O)C3=CN4C=C(C)N=C(C)C4=C3)C2=C1 VKOXUCHMDUPJHP-UHFFFAOYSA-N 0.000 claims 1
- YMCDZHDCXLYIQP-UHFFFAOYSA-N 3-(1,3-dimethylpyrrolo[1,2-a]pyrazin-7-yl)-7-(4-methylpiperazin-1-yl)isochromen-1-one Chemical compound C1CN(C)CCN1C1=CC=C(C=C(OC2=O)C3=CN4C=C(C)N=C(C)C4=C3)C2=C1 YMCDZHDCXLYIQP-UHFFFAOYSA-N 0.000 claims 1
- DFPPDGVHKSQRCP-UHFFFAOYSA-N 3-(1,3-dimethylpyrrolo[1,2-a]pyrazin-7-yl)-7-(4-propan-2-ylpiperazin-1-yl)isochromen-1-one Chemical compound C1CN(C(C)C)CCN1C1=CC=C(C=C(OC2=O)C3=CN4C=C(C)N=C(C)C4=C3)C2=C1 DFPPDGVHKSQRCP-UHFFFAOYSA-N 0.000 claims 1
- XAACNDLSCBBVDS-UHFFFAOYSA-N 3-(2,2-difluoro-1,3-benzodioxol-5-yl)-7-(4-methyl-1,4-diazepan-1-yl)isochromen-1-one Chemical compound C1CN(C)CCCN1C1=CC=C(C=C(OC2=O)C=3C=C4OC(F)(F)OC4=CC=3)C2=C1 XAACNDLSCBBVDS-UHFFFAOYSA-N 0.000 claims 1
- YOZIWSBPSOZHEJ-UHFFFAOYSA-N 3-(2,2-difluoro-1,3-benzodioxol-5-yl)-7-piperazin-1-ylisochromen-1-one Chemical compound C1=C2OC(F)(F)OC2=CC=C1C(OC(=O)C1=C2)=CC1=CC=C2N1CCNCC1 YOZIWSBPSOZHEJ-UHFFFAOYSA-N 0.000 claims 1
- NTIMHKIOWCILEO-UHFFFAOYSA-N 3-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-(4-methylpiperazin-1-yl)isochromen-1-one Chemical compound O1CCOC2=C1C=CC(=C2)C=2OC(C1=CC(=CC=C1C2)N2CCN(CC2)C)=O NTIMHKIOWCILEO-UHFFFAOYSA-N 0.000 claims 1
- YTYVDEJNLXRPOT-CQSZACIVSA-N 3-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-[(3r)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN[C@H](C)CN1C1=CC=C(C=C(OC2=O)C=3C=C4OCCOC4=CC=3)C2=C1 YTYVDEJNLXRPOT-CQSZACIVSA-N 0.000 claims 1
- FFCATLDASLVELR-GASCZTMLSA-N 3-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]isochromen-1-one Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3C=C4OCCOC4=CC=3)C2=C1 FFCATLDASLVELR-GASCZTMLSA-N 0.000 claims 1
- YTYVDEJNLXRPOT-AWEZNQCLSA-N 3-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3C=C4OCCOC4=CC=3)C2=C1 YTYVDEJNLXRPOT-AWEZNQCLSA-N 0.000 claims 1
- DIHQRNHSZKEERZ-UHFFFAOYSA-N 3-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-piperazin-1-ylisochromen-1-one Chemical compound C1=C2C(=O)OC(C=3C=C4OCCOC4=CC=3)=CC2=CC=C1N1CCNCC1 DIHQRNHSZKEERZ-UHFFFAOYSA-N 0.000 claims 1
- FFDLILHNHGJPMY-AWEZNQCLSA-N 3-(2,4-dimethoxyphenyl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound COC1=CC(OC)=CC=C1C1=CC2=CC=C(N3C[C@H](C)NCC3)C=C2C(=O)O1 FFDLILHNHGJPMY-AWEZNQCLSA-N 0.000 claims 1
- XMTQKHGXZPDSNR-ZDUSSCGKSA-N 3-(2-fluoro-4-methoxyphenyl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound FC1=CC(OC)=CC=C1C1=CC2=CC=C(N3C[C@H](C)NCC3)C=C2C(=O)O1 XMTQKHGXZPDSNR-ZDUSSCGKSA-N 0.000 claims 1
- HZFQLHSZXSPVHS-UHFFFAOYSA-N 3-(2-methoxyphenyl)-7-(4-methylpiperazin-1-yl)isochromen-1-one Chemical compound COC1=CC=CC=C1C1=CC2=CC=C(N3CCN(C)CC3)C=C2C(=O)O1 HZFQLHSZXSPVHS-UHFFFAOYSA-N 0.000 claims 1
- LCBWCKJGIRYPMO-AWEZNQCLSA-N 3-(2-methoxyphenyl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound COC1=CC=CC=C1C1=CC2=CC=C(N3C[C@H](C)NCC3)C=C2C(=O)O1 LCBWCKJGIRYPMO-AWEZNQCLSA-N 0.000 claims 1
- AFKHSHXNKQEFCE-UHFFFAOYSA-N 3-(2-methyl-1,3-benzothiazol-5-yl)-7-piperazin-1-ylisochromen-1-one Chemical compound C=1C=C2SC(C)=NC2=CC=1C(OC(=O)C1=C2)=CC1=CC=C2N1CCNCC1 AFKHSHXNKQEFCE-UHFFFAOYSA-N 0.000 claims 1
- QKDCMLJYLGMSGK-UHFFFAOYSA-N 3-(2-methyl-1,3-benzothiazol-6-yl)-7-(4-methylpiperazin-1-yl)isochromen-1-one Chemical compound C1CN(C)CCN1C1=CC=C(C=C(OC2=O)C=3C=C4SC(C)=NC4=CC=3)C2=C1 QKDCMLJYLGMSGK-UHFFFAOYSA-N 0.000 claims 1
- RUFXCZBKBSYKPD-UHFFFAOYSA-N 3-(2-methyl-1,3-benzothiazol-6-yl)-7-(4-propan-2-ylpiperazin-1-yl)isochromen-1-one Chemical compound C1CN(C(C)C)CCN1C1=CC=C(C=C(OC2=O)C=3C=C4SC(C)=NC4=CC=3)C2=C1 RUFXCZBKBSYKPD-UHFFFAOYSA-N 0.000 claims 1
- HVDQRLLJJQHVCY-UHFFFAOYSA-N 3-(2-methyl-1,3-benzothiazol-6-yl)-7-[4-(oxetan-3-yl)piperazin-1-yl]isochromen-1-one Chemical compound C1=C2SC(C)=NC2=CC=C1C(OC(=O)C1=C2)=CC1=CC=C2N(CC1)CCN1C1COC1 HVDQRLLJJQHVCY-UHFFFAOYSA-N 0.000 claims 1
- RMSZLJVANBXOAW-UHFFFAOYSA-N 3-(2-methyl-1,3-benzothiazol-6-yl)-7-piperazin-1-ylisochromen-1-one Chemical compound C1=C2SC(C)=NC2=CC=C1C(OC(=O)C1=C2)=CC1=CC=C2N1CCNCC1 RMSZLJVANBXOAW-UHFFFAOYSA-N 0.000 claims 1
- GJXDWKRDCVVTBW-UHFFFAOYSA-N 3-(2-methyl-1-benzofuran-5-yl)-7-piperazin-1-ylisochromen-1-one Chemical compound CC=1OC2=C(C1)C=C(C=C2)C=2OC(C1=CC(=CC=C1C2)N2CCNCC2)=O GJXDWKRDCVVTBW-UHFFFAOYSA-N 0.000 claims 1
- JVUVATSKMZPTBI-UHFFFAOYSA-N 3-(2-methylindazol-5-yl)-7-(4-methylpiperazin-1-yl)isochromen-1-one Chemical compound C1CN(C)CCN1C1=CC=C(C=C(OC2=O)C3=CC4=CN(C)N=C4C=C3)C2=C1 JVUVATSKMZPTBI-UHFFFAOYSA-N 0.000 claims 1
- VJHJOFDYLVZNCO-UHFFFAOYSA-N 3-(2-methylindazol-5-yl)-7-piperazin-1-ylisochromen-1-one Chemical compound C1=CC2=NN(C)C=C2C=C1C(OC(=O)C1=C2)=CC1=CC=C2N1CCNCC1 VJHJOFDYLVZNCO-UHFFFAOYSA-N 0.000 claims 1
- AOYUTKODKWDUOP-LBPRGKRZSA-N 3-(3,4-dihydroxyphenyl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3C=C(O)C(O)=CC=3)C2=C1 AOYUTKODKWDUOP-LBPRGKRZSA-N 0.000 claims 1
- DUHICLNDLDBYTH-UHFFFAOYSA-N 3-(3,4-dimethoxyphenyl)-7-(4-methylpiperazin-1-yl)isochromen-1-one Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC2=CC=C(N3CCN(C)CC3)C=C2C(=O)O1 DUHICLNDLDBYTH-UHFFFAOYSA-N 0.000 claims 1
- NJYZJCOUGJGYDI-GASCZTMLSA-N 3-(3,4-dimethoxyphenyl)-7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]isochromen-1-one Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC2=CC=C(N3C[C@@H](C)N[C@@H](C)C3)C=C2C(=O)O1 NJYZJCOUGJGYDI-GASCZTMLSA-N 0.000 claims 1
- FBJDRSNXLDHKBO-HNNXBMFYSA-N 3-(3,4-dimethoxyphenyl)-7-[(3s)-3,4-dimethylpiperazin-1-yl]isochromen-1-one Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC2=CC=C(N3C[C@H](C)N(C)CC3)C=C2C(=O)O1 FBJDRSNXLDHKBO-HNNXBMFYSA-N 0.000 claims 1
- FFVOWQLMMLMKRX-AWEZNQCLSA-N 3-(3,4-dimethoxyphenyl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC2=CC=C(N3C[C@H](C)NCC3)C=C2C(=O)O1 FFVOWQLMMLMKRX-AWEZNQCLSA-N 0.000 claims 1
- YLMGJLMUAAUMNC-UHFFFAOYSA-N 3-(3,4-dimethoxyphenyl)-7-piperazin-1-ylisochromen-1-one Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC2=CC=C(N3CCNCC3)C=C2C(=O)O1 YLMGJLMUAAUMNC-UHFFFAOYSA-N 0.000 claims 1
- OSEFOZOIABHORM-LBPRGKRZSA-N 3-(3,5-difluoro-4-methoxyphenyl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1=C(F)C(OC)=C(F)C=C1C1=CC2=CC=C(N3C[C@H](C)NCC3)C=C2C(=O)O1 OSEFOZOIABHORM-LBPRGKRZSA-N 0.000 claims 1
- USOVNYDOTAWWKX-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-7-piperazin-1-ylisochromen-1-one Chemical compound FC1=CC(F)=CC(C=2OC(=O)C3=CC(=CC=C3C=2)N2CCNCC2)=C1 USOVNYDOTAWWKX-UHFFFAOYSA-N 0.000 claims 1
- JHAIIMZPZCLZKV-ZDUSSCGKSA-N 3-(3-chloro-4-methoxyphenyl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1=C(Cl)C(OC)=CC=C1C1=CC2=CC=C(N3C[C@H](C)NCC3)C=C2C(=O)O1 JHAIIMZPZCLZKV-ZDUSSCGKSA-N 0.000 claims 1
- AHRDCSGRRJKJEX-ZDUSSCGKSA-N 3-(3-fluoro-4-methoxyphenyl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1=C(F)C(OC)=CC=C1C1=CC2=CC=C(N3C[C@H](C)NCC3)C=C2C(=O)O1 AHRDCSGRRJKJEX-ZDUSSCGKSA-N 0.000 claims 1
- RFTDWCCIVAWAQL-ZDUSSCGKSA-N 3-(3-hydroxyphenyl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3C=C(O)C=CC=3)C2=C1 RFTDWCCIVAWAQL-ZDUSSCGKSA-N 0.000 claims 1
- OVBYKFYQWNTJDM-UHFFFAOYSA-N 3-(3-methoxyphenyl)-7-(4-methylpiperazin-1-yl)isochromen-1-one Chemical compound COC1=CC=CC(C=2OC(=O)C3=CC(=CC=C3C=2)N2CCN(C)CC2)=C1 OVBYKFYQWNTJDM-UHFFFAOYSA-N 0.000 claims 1
- IWIIBNHQUADCAW-UHFFFAOYSA-N 3-(3-methoxyphenyl)-7-piperazin-1-ylisochromen-1-one Chemical compound COC1=CC=CC(C=2OC(=O)C3=CC(=CC=C3C=2)N2CCNCC2)=C1 IWIIBNHQUADCAW-UHFFFAOYSA-N 0.000 claims 1
- BCWJBGUYUSAWDB-HNNXBMFYSA-N 3-(4-ethoxyphenyl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1=CC(OCC)=CC=C1C1=CC2=CC=C(N3C[C@H](C)NCC3)C=C2C(=O)O1 BCWJBGUYUSAWDB-HNNXBMFYSA-N 0.000 claims 1
- QCZRHNHWJXCHCP-UHFFFAOYSA-N 3-(4-ethoxyphenyl)-7-piperazin-1-ylisochromen-1-one Chemical compound C1=CC(OCC)=CC=C1C1=CC2=CC=C(N3CCNCC3)C=C2C(=O)O1 QCZRHNHWJXCHCP-UHFFFAOYSA-N 0.000 claims 1
- DZXVPQVQYHFRHK-ZDUSSCGKSA-N 3-(4-fluoro-3-methoxyphenyl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1=C(F)C(OC)=CC(C=2OC(=O)C3=CC(=CC=C3C=2)N2C[C@H](C)NCC2)=C1 DZXVPQVQYHFRHK-ZDUSSCGKSA-N 0.000 claims 1
- SJQCCYLDNFCWHV-UHFFFAOYSA-N 3-(4-methoxyphenyl)-7-(4-methylpiperazin-1-yl)isochromen-1-one Chemical compound C1=CC(OC)=CC=C1C1=CC2=CC=C(N3CCN(C)CC3)C=C2C(=O)O1 SJQCCYLDNFCWHV-UHFFFAOYSA-N 0.000 claims 1
- PRRLCIVMXKUMIM-AWEZNQCLSA-N 3-(4-methoxyphenyl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1=CC(OC)=CC=C1C1=CC2=CC=C(N3C[C@H](C)NCC3)C=C2C(=O)O1 PRRLCIVMXKUMIM-AWEZNQCLSA-N 0.000 claims 1
- AQQCUSSDYYCHML-UHFFFAOYSA-N 3-(4-methoxyphenyl)-7-piperazin-1-ylisochromen-1-one Chemical compound C1=CC(OC)=CC=C1C1=CC2=CC=C(N3CCNCC3)C=C2C(=O)O1 AQQCUSSDYYCHML-UHFFFAOYSA-N 0.000 claims 1
- PNSHLQYQODCZBP-ZDUSSCGKSA-N 3-(5-fluoro-2-methoxyphenyl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound COC1=CC=C(F)C=C1C1=CC2=CC=C(N3C[C@H](C)NCC3)C=C2C(=O)O1 PNSHLQYQODCZBP-ZDUSSCGKSA-N 0.000 claims 1
- XXQSIQIKTMDLDE-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-(1,2,3,6-tetrahydropyridin-4-yl)isochromen-1-one Chemical compound N1=C2C(C)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2C1=CCNCC1 XXQSIQIKTMDLDE-UHFFFAOYSA-N 0.000 claims 1
- GUMCGNFWXMALGM-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-(1-ethyl-3,6-dihydro-2h-pyridin-4-yl)isochromen-1-one Chemical compound C1N(CC)CCC(C=2C=C3C(=O)OC(=CC3=CC=2)C=2N=C3C(C)=NC(C)=CN3C=2)=C1 GUMCGNFWXMALGM-UHFFFAOYSA-N 0.000 claims 1
- IFFFIGBSTGOFBF-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-(1-ethylpiperidin-4-yl)isochromen-1-one Chemical compound C1CN(CC)CCC1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 IFFFIGBSTGOFBF-UHFFFAOYSA-N 0.000 claims 1
- WUMORCIBRJUNCG-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)isochromen-1-one Chemical compound CC=1N=C(C=2N(C=1)C=C(N=2)C=1OC(C2=CC(=CC=C2C=1)C=1CCN(CC=1)C)=O)C WUMORCIBRJUNCG-UHFFFAOYSA-N 0.000 claims 1
- ZVSGJGATQDYOQK-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-(1-methylpiperidin-4-yl)isochromen-1-one Chemical compound C1CN(C)CCC1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 ZVSGJGATQDYOQK-UHFFFAOYSA-N 0.000 claims 1
- CVAXFFBONNMMNT-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-(1-propan-2-yl-3,6-dihydro-2h-pyridin-4-yl)isochromen-1-one Chemical compound C1N(C(C)C)CCC(C=2C=C3C(=O)OC(=CC3=CC=2)C=2N=C3C(C)=NC(C)=CN3C=2)=C1 CVAXFFBONNMMNT-UHFFFAOYSA-N 0.000 claims 1
- ZSSQRFMZFLFLPH-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-(1-propyl-3,6-dihydro-2h-pyridin-4-yl)isochromen-1-one Chemical compound C1N(CCC)CCC(C=2C=C3C(=O)OC(=CC3=CC=2)C=2N=C3C(C)=NC(C)=CN3C=2)=C1 ZSSQRFMZFLFLPH-UHFFFAOYSA-N 0.000 claims 1
- ODWSNBWWEVBHJT-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-(1-propylpiperidin-4-yl)isochromen-1-one Chemical compound C1CN(CCC)CCC1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 ODWSNBWWEVBHJT-UHFFFAOYSA-N 0.000 claims 1
- PARMDVGLLALRHB-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-(4-ethylpiperazin-1-yl)isochromen-1-one Chemical compound C1CN(CC)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 PARMDVGLLALRHB-UHFFFAOYSA-N 0.000 claims 1
- XYRFITNWPNSDGK-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-(4-hydroxypiperidin-1-yl)isochromen-1-one Chemical compound N1=C2C(C)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2N1CCC(O)CC1 XYRFITNWPNSDGK-UHFFFAOYSA-N 0.000 claims 1
- IJTUIAVNGJAVKK-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-(4-methylpiperazin-1-yl)isochromen-1-one Chemical compound C1CN(C)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 IJTUIAVNGJAVKK-UHFFFAOYSA-N 0.000 claims 1
- ARPYYIRKZPVVKD-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-(4-propylpiperazin-1-yl)isochromen-1-one Chemical compound C1CN(CCC)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 ARPYYIRKZPVVKD-UHFFFAOYSA-N 0.000 claims 1
- LUDRVJSGZPFNML-MRXNPFEDSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3R)-4-(2-hydroxyethyl)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound CC=1N=C(C=2N(C=1)C=C(N=2)C=1OC(C2=CC(=CC=C2C=1)N1C[C@H](N(CC1)CCO)C)=O)C LUDRVJSGZPFNML-MRXNPFEDSA-N 0.000 claims 1
- LUDRVJSGZPFNML-INIZCTEOSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3S)-4-(2-hydroxyethyl)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound CC=1N=C(C=2N(C1)C=C(N2)C=2OC(C1=CC(=CC=C1C2)N2C[C@@H](N(CC2)CCO)C)=O)C LUDRVJSGZPFNML-INIZCTEOSA-N 0.000 claims 1
- RGZYSTXERLEELN-CALCHBBNSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3S,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]isochromen-1-one Chemical compound CC=1N=C(C=2N(C=1)C=C(N=2)C=1OC(C2=CC(=CC=C2C=1)N1C[C@H](N([C@H](C1)C)CC)C)=O)C RGZYSTXERLEELN-CALCHBBNSA-N 0.000 claims 1
- YPLBGCUKFPRADT-OAHLLOKOSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3r)-3,4-dimethylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN(C)[C@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 YPLBGCUKFPRADT-OAHLLOKOSA-N 0.000 claims 1
- WULDGYXHQGRJJO-QGZVFWFLSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3r)-3-methyl-4-propan-2-ylpiperazin-1-yl]isochromen-1-one Chemical compound C1[C@@H](C)N(C(C)C)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 WULDGYXHQGRJJO-QGZVFWFLSA-N 0.000 claims 1
- YHBUPDNDBACRSA-QGZVFWFLSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3r)-3-methyl-4-propylpiperazin-1-yl]isochromen-1-one Chemical compound C1[C@@H](C)N(CCC)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 YHBUPDNDBACRSA-QGZVFWFLSA-N 0.000 claims 1
- SBBSLHUOUADLSA-CYBMUJFWSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3r)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN[C@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 SBBSLHUOUADLSA-CYBMUJFWSA-N 0.000 claims 1
- AXUQXEIZOPVNDW-QGZVFWFLSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3r)-4-(2-methoxyethyl)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1[C@@H](C)N(CCOC)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 AXUQXEIZOPVNDW-QGZVFWFLSA-N 0.000 claims 1
- IYYVLSASJGIZNR-MRXNPFEDSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3r)-4-ethyl-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1[C@@H](C)N(CC)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 IYYVLSASJGIZNR-MRXNPFEDSA-N 0.000 claims 1
- NKFZJKOQLJNYBE-HDICACEKSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3r,5s)-3,5-dimethyl-4-propylpiperazin-1-yl]isochromen-1-one Chemical compound C1[C@@H](C)N(CCC)[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 NKFZJKOQLJNYBE-HDICACEKSA-N 0.000 claims 1
- ORYJQOAIKOUOOC-OKILXGFUSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]isochromen-1-one Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 ORYJQOAIKOUOOC-OKILXGFUSA-N 0.000 claims 1
- YPLBGCUKFPRADT-HNNXBMFYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3s)-3,4-dimethylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN(C)[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 YPLBGCUKFPRADT-HNNXBMFYSA-N 0.000 claims 1
- XNSMYECFZLLEEX-INIZCTEOSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3s)-3-methyl-4-(oxetan-3-yl)piperazin-1-yl]isochromen-1-one Chemical compound C([C@@H]1C)N(C=2C=C3C(=O)OC(=CC3=CC=2)C=2N=C3C(C)=NC(C)=CN3C=2)CCN1C1COC1 XNSMYECFZLLEEX-INIZCTEOSA-N 0.000 claims 1
- WULDGYXHQGRJJO-KRWDZBQOSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3s)-3-methyl-4-propan-2-ylpiperazin-1-yl]isochromen-1-one Chemical compound C1[C@H](C)N(C(C)C)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 WULDGYXHQGRJJO-KRWDZBQOSA-N 0.000 claims 1
- YHBUPDNDBACRSA-KRWDZBQOSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3s)-3-methyl-4-propylpiperazin-1-yl]isochromen-1-one Chemical compound C1[C@H](C)N(CCC)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 YHBUPDNDBACRSA-KRWDZBQOSA-N 0.000 claims 1
- SBBSLHUOUADLSA-ZDUSSCGKSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 SBBSLHUOUADLSA-ZDUSSCGKSA-N 0.000 claims 1
- AXUQXEIZOPVNDW-KRWDZBQOSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3s)-4-(2-methoxyethyl)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1[C@H](C)N(CCOC)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 AXUQXEIZOPVNDW-KRWDZBQOSA-N 0.000 claims 1
- IYYVLSASJGIZNR-INIZCTEOSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3s)-4-ethyl-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1[C@H](C)N(CC)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 IYYVLSASJGIZNR-INIZCTEOSA-N 0.000 claims 1
- XFSNMNNOIQRXTB-IYBDPMFKSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3s,5r)-3,4,5-trimethylpiperazin-1-yl]isochromen-1-one Chemical compound C1[C@@H](C)N(C)[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 XFSNMNNOIQRXTB-IYBDPMFKSA-N 0.000 claims 1
- ZWBHLGVOQDQGQA-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[1-(2-methoxyethyl)-3,6-dihydro-2h-pyridin-4-yl]isochromen-1-one Chemical compound C1N(CCOC)CCC(C=2C=C3C(=O)OC(=CC3=CC=2)C=2N=C3C(C)=NC(C)=CN3C=2)=C1 ZWBHLGVOQDQGQA-UHFFFAOYSA-N 0.000 claims 1
- LXHCYBQZXVSVSP-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[1-(oxetan-3-yl)-3,6-dihydro-2h-pyridin-4-yl]isochromen-1-one Chemical compound N1=C2C(C)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2C(CC1)=CCN1C1COC1 LXHCYBQZXVSVSP-UHFFFAOYSA-N 0.000 claims 1
- KXYOZRDCXIJSBU-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[1-(oxetan-3-yl)piperidin-4-yl]isochromen-1-one Chemical compound N1=C2C(C)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2C(CC1)CCN1C1COC1 KXYOZRDCXIJSBU-UHFFFAOYSA-N 0.000 claims 1
- YWGBAYRIEZOWAJ-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[4-(2-hydroxyethyl)piperazin-1-yl]isochromen-1-one Chemical compound N1=C2C(C)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2N1CCN(CCO)CC1 YWGBAYRIEZOWAJ-UHFFFAOYSA-N 0.000 claims 1
- IJBUZQWRIVXNNY-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[4-(2-methoxyethyl)piperazin-1-yl]isochromen-1-one Chemical compound C1CN(CCOC)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 IJBUZQWRIVXNNY-UHFFFAOYSA-N 0.000 claims 1
- APWIVCWGSCVWKV-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[4-(oxetan-3-yl)piperazin-1-yl]isochromen-1-one Chemical compound N1=C2C(C)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2N(CC1)CCN1C1COC1 APWIVCWGSCVWKV-UHFFFAOYSA-N 0.000 claims 1
- IWZCMPUMVWMHLI-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-piperazin-1-ylisochromen-1-one Chemical compound N1=C2C(C)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2N1CCNCC1 IWZCMPUMVWMHLI-UHFFFAOYSA-N 0.000 claims 1
- YDDIBYQNXLJMPU-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-piperidin-4-ylisochromen-1-one Chemical compound N1=C2C(C)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2C1CCNCC1 YDDIBYQNXLJMPU-UHFFFAOYSA-N 0.000 claims 1
- UFCFFECJJCCTAF-UHFFFAOYSA-N 3-(6-chloro-8-methylimidazo[1,2-a]pyrazin-2-yl)-7-(1,2,3,6-tetrahydropyridin-4-yl)isochromen-1-one Chemical compound N1=C2C(C)=NC(Cl)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2C1=CCNCC1 UFCFFECJJCCTAF-UHFFFAOYSA-N 0.000 claims 1
- MDCCGEZNAMVHIF-UHFFFAOYSA-N 3-(6-chloro-8-methylimidazo[1,2-a]pyrazin-2-yl)-7-(4-ethylpiperazin-1-yl)isochromen-1-one Chemical compound C1CN(CC)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(Cl)=CN4C=3)C2=C1 MDCCGEZNAMVHIF-UHFFFAOYSA-N 0.000 claims 1
- YUIHGIDMTNXZJU-UHFFFAOYSA-N 3-(6-chloro-8-methylimidazo[1,2-a]pyrazin-2-yl)-7-(4-methylpiperazin-1-yl)isochromen-1-one Chemical compound C1CN(C)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(Cl)=CN4C=3)C2=C1 YUIHGIDMTNXZJU-UHFFFAOYSA-N 0.000 claims 1
- KWSJOLNZNNPCAX-UHFFFAOYSA-N 3-(6-chloro-8-methylimidazo[1,2-a]pyrazin-2-yl)-7-(4-propan-2-ylpiperazin-1-yl)isochromen-1-one Chemical compound C1CN(C(C)C)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(Cl)=CN4C=3)C2=C1 KWSJOLNZNNPCAX-UHFFFAOYSA-N 0.000 claims 1
- XSKHHIIAGHTZKX-GFCCVEGCSA-N 3-(6-chloro-8-methylimidazo[1,2-a]pyrazin-2-yl)-7-[(3r)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN[C@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(Cl)=CN4C=3)C2=C1 XSKHHIIAGHTZKX-GFCCVEGCSA-N 0.000 claims 1
- YYBIVTCGSKFKRP-BETUJISGSA-N 3-(6-chloro-8-methylimidazo[1,2-a]pyrazin-2-yl)-7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]isochromen-1-one Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(Cl)=CN4C=3)C2=C1 YYBIVTCGSKFKRP-BETUJISGSA-N 0.000 claims 1
- AZYWZESMULZKSP-ZDUSSCGKSA-N 3-(6-chloro-8-methylimidazo[1,2-a]pyrazin-2-yl)-7-[(3s)-3,4-dimethylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN(C)[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(Cl)=CN4C=3)C2=C1 AZYWZESMULZKSP-ZDUSSCGKSA-N 0.000 claims 1
- XSKHHIIAGHTZKX-LBPRGKRZSA-N 3-(6-chloro-8-methylimidazo[1,2-a]pyrazin-2-yl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(Cl)=CN4C=3)C2=C1 XSKHHIIAGHTZKX-LBPRGKRZSA-N 0.000 claims 1
- NZSUNMSSAUJFBG-UHFFFAOYSA-N 3-(6-chloro-8-methylimidazo[1,2-a]pyrazin-2-yl)-7-piperazin-1-ylisochromen-1-one Chemical compound N1=C2C(C)=NC(Cl)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2N1CCNCC1 NZSUNMSSAUJFBG-UHFFFAOYSA-N 0.000 claims 1
- VLDHIEYXICLZCJ-UHFFFAOYSA-N 3-(6-methylimidazo[1,2-a]pyrazin-2-yl)-7-(4-methylpiperazin-1-yl)isochromen-1-one Chemical compound CC=1N=CC=2N(C=1)C=C(N=2)C=1OC(C2=CC(=CC=C2C=1)N1CCN(CC1)C)=O VLDHIEYXICLZCJ-UHFFFAOYSA-N 0.000 claims 1
- JEKUTIKQZXQKEH-UHFFFAOYSA-N 3-(6-methylimidazo[1,2-a]pyrazin-2-yl)-7-(4-propan-2-ylpiperazin-1-yl)isochromen-1-one Chemical compound C1CN(C(C)C)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C=NC(C)=CN4C=3)C2=C1 JEKUTIKQZXQKEH-UHFFFAOYSA-N 0.000 claims 1
- OTPXSQXKZURXMD-IYBDPMFKSA-N 3-(6-methylimidazo[1,2-a]pyrazin-2-yl)-7-[(3S,5R)-3,4,5-trimethylpiperazin-1-yl]isochromen-1-one Chemical compound CC=1N=CC=2N(C=1)C=C(N=2)C=1OC(C2=CC(=CC=C2C=1)N1C[C@H](N([C@H](C1)C)C)C)=O OTPXSQXKZURXMD-IYBDPMFKSA-N 0.000 claims 1
- WHWNJMWELLRCKR-CYBMUJFWSA-N 3-(6-methylimidazo[1,2-a]pyrazin-2-yl)-7-[(3r)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN[C@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=C4C=NC(C)=CN4C=3)C2=C1 WHWNJMWELLRCKR-CYBMUJFWSA-N 0.000 claims 1
- WHWNJMWELLRCKR-ZDUSSCGKSA-N 3-(6-methylimidazo[1,2-a]pyrazin-2-yl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=C4C=NC(C)=CN4C=3)C2=C1 WHWNJMWELLRCKR-ZDUSSCGKSA-N 0.000 claims 1
- BMBNHMVNXUHKOM-UHFFFAOYSA-N 3-(6-methylimidazo[1,2-a]pyrazin-2-yl)-7-piperazin-1-ylisochromen-1-one Chemical compound N1=C2C=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2N1CCNCC1 BMBNHMVNXUHKOM-UHFFFAOYSA-N 0.000 claims 1
- ZUBXCOBCOQCRBD-UHFFFAOYSA-N 3-(8-chloroimidazo[1,2-a]pyridin-2-yl)-7-(4-methylpiperazin-1-yl)isochromen-1-one Chemical compound C1CN(C)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C(Cl)=CC=CN4C=3)C2=C1 ZUBXCOBCOQCRBD-UHFFFAOYSA-N 0.000 claims 1
- KNTUMPDFVFOSHG-ZDUSSCGKSA-N 3-(8-chloroimidazo[1,2-a]pyridin-2-yl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=C4C(Cl)=CC=CN4C=3)C2=C1 KNTUMPDFVFOSHG-ZDUSSCGKSA-N 0.000 claims 1
- MDELGUIXEOXHDA-UHFFFAOYSA-N 3-(8-chloroimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylisochromen-1-one Chemical compound N1=C2C(Cl)=CC=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2N1CCNCC1 MDELGUIXEOXHDA-UHFFFAOYSA-N 0.000 claims 1
- AYCRLKPZXIQLEX-UHFFFAOYSA-N 3-(8-ethyl-6-methylimidazo[1,2-a]pyrazin-2-yl)-7-(1,2,3,6-tetrahydropyridin-4-yl)isochromen-1-one Chemical compound N1=C2C(CC)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2C1=CCNCC1 AYCRLKPZXIQLEX-UHFFFAOYSA-N 0.000 claims 1
- DVSMDMAVJMIYCS-UHFFFAOYSA-N 3-(8-ethyl-6-methylimidazo[1,2-a]pyrazin-2-yl)-7-(4-methylpiperazin-1-yl)isochromen-1-one Chemical compound N1=C2C(CC)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2N1CCN(C)CC1 DVSMDMAVJMIYCS-UHFFFAOYSA-N 0.000 claims 1
- YXISRRKNACUBFX-CQSZACIVSA-N 3-(8-ethyl-6-methylimidazo[1,2-a]pyrazin-2-yl)-7-[(3r)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound N1=C2C(CC)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2N1CCN[C@H](C)C1 YXISRRKNACUBFX-CQSZACIVSA-N 0.000 claims 1
- YXISRRKNACUBFX-AWEZNQCLSA-N 3-(8-ethyl-6-methylimidazo[1,2-a]pyrazin-2-yl)-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound N1=C2C(CC)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2N1CCN[C@@H](C)C1 YXISRRKNACUBFX-AWEZNQCLSA-N 0.000 claims 1
- AXUGGDTUUKGNIN-CALCHBBNSA-N 3-(8-ethyl-6-methylimidazo[1,2-a]pyrazin-2-yl)-7-[(3s,5r)-3,4,5-trimethylpiperazin-1-yl]isochromen-1-one Chemical compound N1=C2C(CC)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2N1C[C@H](C)N(C)[C@H](C)C1 AXUGGDTUUKGNIN-CALCHBBNSA-N 0.000 claims 1
- PHCLTSBGAGKKHH-UHFFFAOYSA-N 3-(8-ethyl-6-methylimidazo[1,2-a]pyrazin-2-yl)-7-piperazin-1-ylisochromen-1-one Chemical compound C(C)C=1C=2N(C=C(N1)C)C=C(N2)C=2OC(C1=CC(=CC=C1C2)N2CCNCC2)=O PHCLTSBGAGKKHH-UHFFFAOYSA-N 0.000 claims 1
- NOCIZSJEWMEZNY-ZDUSSCGKSA-N 3-[3-(difluoromethoxy)phenyl]-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3C=C(OC(F)F)C=CC=3)C2=C1 NOCIZSJEWMEZNY-ZDUSSCGKSA-N 0.000 claims 1
- WGEUYBUUNNCCQQ-ZDUSSCGKSA-N 3-[4-(difluoromethoxy)phenyl]-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3C=CC(OC(F)F)=CC=3)C2=C1 WGEUYBUUNNCCQQ-ZDUSSCGKSA-N 0.000 claims 1
- YKCQDLNLJRLQOU-UHFFFAOYSA-N 3-imidazo[1,2-a]pyridin-2-yl-7-(4-methylpiperazin-1-yl)isochromen-1-one Chemical compound C1CN(C)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C=CC=CN4C=3)C2=C1 YKCQDLNLJRLQOU-UHFFFAOYSA-N 0.000 claims 1
- UYMIYSXYKYFAFL-UHFFFAOYSA-N 3-imidazo[1,2-a]pyridin-2-yl-7-piperazin-1-ylisochromen-1-one Chemical compound C1=C2C(=O)OC(C=3N=C4C=CC=CN4C=3)=CC2=CC=C1N1CCNCC1 UYMIYSXYKYFAFL-UHFFFAOYSA-N 0.000 claims 1
- YPXQXVZXHKITSV-UHFFFAOYSA-N 3-imidazo[2,1-b][1,3]thiazol-6-yl-7-(4-methylpiperazin-1-yl)isochromen-1-one Chemical compound C1CN(C)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4SC=CN4C=3)C2=C1 YPXQXVZXHKITSV-UHFFFAOYSA-N 0.000 claims 1
- VTUYMANSJOUESQ-LBPRGKRZSA-N 3-imidazo[2,1-b][1,3]thiazol-6-yl-7-[(3s)-3-methylpiperazin-1-yl]isochromen-1-one Chemical compound C1CN[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=C4SC=CN4C=3)C2=C1 VTUYMANSJOUESQ-LBPRGKRZSA-N 0.000 claims 1
- IZBMALDRECDQAK-UHFFFAOYSA-N 3-imidazo[2,1-b][1,3]thiazol-6-yl-7-piperazin-1-ylisochromen-1-one Chemical compound C1=C2C(=O)OC(C=3N=C4SC=CN4C=3)=CC2=CC=C1N1CCNCC1 IZBMALDRECDQAK-UHFFFAOYSA-N 0.000 claims 1
- YHWHYGSWDMFDLQ-UHFFFAOYSA-N 7-(1,4-diazepan-1-yl)-3-(3-methoxyphenyl)isochromen-1-one Chemical compound COC1=CC=CC(C=2OC(=O)C3=CC(=CC=C3C=2)N2CCNCCC2)=C1 YHWHYGSWDMFDLQ-UHFFFAOYSA-N 0.000 claims 1
- SMZSYICEMBSLRA-UHFFFAOYSA-N 7-(1-cyclobutyl-3,6-dihydro-2h-pyridin-4-yl)-3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound N1=C2C(C)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2C(CC1)=CCN1C1CCC1 SMZSYICEMBSLRA-UHFFFAOYSA-N 0.000 claims 1
- UCCPBFKKTGXNNZ-UHFFFAOYSA-N 7-(1-cyclobutylpiperidin-4-yl)-3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound N1=C2C(C)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2C(CC1)CCN1C1CCC1 UCCPBFKKTGXNNZ-UHFFFAOYSA-N 0.000 claims 1
- BATIIHYXGIRGIJ-UHFFFAOYSA-N 7-(1-cyclopropyl-3,6-dihydro-2h-pyridin-4-yl)-3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound N1=C2C(C)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2C(CC1)=CCN1C1CC1 BATIIHYXGIRGIJ-UHFFFAOYSA-N 0.000 claims 1
- YHZCLFQUTMKJQF-UHFFFAOYSA-N 7-(4-cyclobutylpiperazin-1-yl)-3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound N1=C2C(C)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2N(CC1)CCN1C1CCC1 YHZCLFQUTMKJQF-UHFFFAOYSA-N 0.000 claims 1
- SZSRSHSBPSVCQJ-UHFFFAOYSA-N 7-(4-cyclopropylpiperazin-1-yl)-3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound N1=C2C(C)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2N(CC1)CCN1C1CC1 SZSRSHSBPSVCQJ-UHFFFAOYSA-N 0.000 claims 1
- AQQLCAIKLCHXRF-UHFFFAOYSA-N 7-(4-methylpiperazin-1-yl)-3-pyridin-2-ylisochromen-1-one Chemical compound C1CN(C)CCN1C1=CC=C(C=C(OC2=O)C=3N=CC=CC=3)C2=C1 AQQLCAIKLCHXRF-UHFFFAOYSA-N 0.000 claims 1
- DODIFWVGHVVVDW-UHFFFAOYSA-N 7-(4-tert-butylpiperazin-1-yl)-3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound N1=C2C(C)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2N1CCN(C(C)(C)C)CC1 DODIFWVGHVVVDW-UHFFFAOYSA-N 0.000 claims 1
- BYYMEGVKBVOISR-OAHLLOKOSA-N 7-[(3R)-3,4-dimethylpiperazin-1-yl]-3-(6-methylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound C[C@@H]1CN(CCN1C)C1=CC=C2C=C(OC(C2=C1)=O)C=1N=C2N(C=C(N=C2)C)C=1 BYYMEGVKBVOISR-OAHLLOKOSA-N 0.000 claims 1
- JBMCZYQZVFWZGY-MRXNPFEDSA-N 7-[(3R)-4-(2-hydroxyethyl)-3-methylpiperazin-1-yl]-3-(6-methylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound OCCN1[C@@H](CN(CC1)C1=CC=C2C=C(OC(C2=C1)=O)C=1N=C2N(C=C(N=C2)C)C=1)C JBMCZYQZVFWZGY-MRXNPFEDSA-N 0.000 claims 1
- AFLXBCWJTGSHOO-MRXNPFEDSA-N 7-[(3R)-4-ethyl-3-methylpiperazin-1-yl]-3-(6-methylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound C(C)N1[C@@H](CN(CC1)C1=CC=C2C=C(OC(C2=C1)=O)C=1N=C2N(C=C(N=C2)C)C=1)C AFLXBCWJTGSHOO-MRXNPFEDSA-N 0.000 claims 1
- XYTDPOPVHBBIJI-KRWDZBQOSA-N 7-[(3S)-4-cyclobutyl-3-methylpiperazin-1-yl]-3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound C1(CCC1)N1[C@H](CN(CC1)C1=CC=C2C=C(OC(C2=C1)=O)C=1N=C2N(C=C(N=C2C)C)C=1)C XYTDPOPVHBBIJI-KRWDZBQOSA-N 0.000 claims 1
- QUSRZSMIFMSZOC-CALCHBBNSA-N 7-[(3S,5R)-4-(2-hydroxyethyl)-3,5-dimethylpiperazin-1-yl]-3-(6-methylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound OCCN1[C@@H](CN(C[C@@H]1C)C1=CC=C2C=C(OC(C2=C1)=O)C=1N=C2N(C=C(N=C2)C)C=1)C QUSRZSMIFMSZOC-CALCHBBNSA-N 0.000 claims 1
- WNCPQHROCJQIKD-CALCHBBNSA-N 7-[(3S,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]-3-(6-methylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound C(C)N1[C@@H](CN(C[C@@H]1C)C1=CC=C2C=C(OC(C2=C1)=O)C=1N=C2N(C=C(N=C2)C)C=1)C WNCPQHROCJQIKD-CALCHBBNSA-N 0.000 claims 1
- JNLGVXPMPDMWMI-GASCZTMLSA-N 7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-3-(2-methoxyphenyl)isochromen-1-one Chemical compound COC1=CC=CC=C1C1=CC2=CC=C(N3C[C@@H](C)N[C@@H](C)C3)C=C2C(=O)O1 JNLGVXPMPDMWMI-GASCZTMLSA-N 0.000 claims 1
- SRNJBJDBRZODFC-GASCZTMLSA-N 7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-3-(4-methoxyphenyl)isochromen-1-one Chemical compound C1=CC(OC)=CC=C1C1=CC2=CC=C(N3C[C@@H](C)N[C@@H](C)C3)C=C2C(=O)O1 SRNJBJDBRZODFC-GASCZTMLSA-N 0.000 claims 1
- QSRCVRSAAKULCY-GASCZTMLSA-N 7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-3-(6-methylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=C4C=NC(C)=CN4C=3)C2=C1 QSRCVRSAAKULCY-GASCZTMLSA-N 0.000 claims 1
- ZLVCNXFDXQSSEZ-GASCZTMLSA-N 7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-3-(8-ethyl-6-methylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound N1=C2C(CC)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2N1C[C@H](C)N[C@H](C)C1 ZLVCNXFDXQSSEZ-GASCZTMLSA-N 0.000 claims 1
- BYYMEGVKBVOISR-HNNXBMFYSA-N 7-[(3s)-3,4-dimethylpiperazin-1-yl]-3-(6-methylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound C1CN(C)[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=C4C=NC(C)=CN4C=3)C2=C1 BYYMEGVKBVOISR-HNNXBMFYSA-N 0.000 claims 1
- OPYYIKXBAJTQGR-INIZCTEOSA-N 7-[(3s)-3,4-dimethylpiperazin-1-yl]-3-(8-ethyl-6-methylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound N1=C2C(CC)=NC(C)=CN2C=C1C(OC(=O)C1=C2)=CC1=CC=C2N1CCN(C)[C@@H](C)C1 OPYYIKXBAJTQGR-INIZCTEOSA-N 0.000 claims 1
- VUAAOTFCUYKDQG-ZDUSSCGKSA-N 7-[(3s)-3-methylpiperazin-1-yl]-3-pyridin-2-ylisochromen-1-one Chemical compound C1CN[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=CC=CC=3)C2=C1 VUAAOTFCUYKDQG-ZDUSSCGKSA-N 0.000 claims 1
- AFLXBCWJTGSHOO-INIZCTEOSA-N 7-[(3s)-4-ethyl-3-methylpiperazin-1-yl]-3-(6-methylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound C1[C@H](C)N(CC)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C=NC(C)=CN4C=3)C2=C1 AFLXBCWJTGSHOO-INIZCTEOSA-N 0.000 claims 1
- ADFNONMOJNSXIQ-GASCZTMLSA-N 7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]-3-(3-methoxyphenyl)isochromen-1-one Chemical compound COC1=CC=CC(C=2OC(=O)C3=CC(=CC=C3C=2)N2C[C@@H](C)N[C@@H](C)C2)=C1 ADFNONMOJNSXIQ-GASCZTMLSA-N 0.000 claims 1
- SXMISJTZMICEHO-OKILXGFUSA-N 7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]-3-pyridin-2-ylisochromen-1-one Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=CC=C(C=C(OC2=O)C=3N=CC=CC=3)C2=C1 SXMISJTZMICEHO-OKILXGFUSA-N 0.000 claims 1
- PLPJGODBJXXUSU-HDICACEKSA-N 7-[(3s,5r)-4-cyclobutyl-3,5-dimethylpiperazin-1-yl]-3-(6-methylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound N1([C@H](C)CN(C[C@@H]1C)C=1C=C2C(=O)OC(=CC2=CC=1)C=1N=C2C=NC(C)=CN2C=1)C1CCC1 PLPJGODBJXXUSU-HDICACEKSA-N 0.000 claims 1
- REHVZHNXMDVBQZ-GOSISDBHSA-N 7-[(8aR)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]-3-(6-methylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound C1[C@@H]2N(CCN1C1=CC=C3C=C(OC(C3=C1)=O)C=1N=C3N(C=C(N=C3)C)C=1)CCC2 REHVZHNXMDVBQZ-GOSISDBHSA-N 0.000 claims 1
- CMXCYZPTSSHEJE-OAQYLSRUSA-N 7-[(8ar)-3,4,6,7,8,8a-hexahydro-1h-pyrrolo[1,2-a]pyrazin-2-yl]-3-(1,3-dimethylpyrrolo[1,2-a]pyrazin-7-yl)isochromen-1-one Chemical compound C1CN2CCC[C@@H]2CN1C(C=C1C(=O)O2)=CC=C1C=C2C1=CN2C=C(C)N=C(C)C2=C1 CMXCYZPTSSHEJE-OAQYLSRUSA-N 0.000 claims 1
- ULXIJKBDXFJGQW-LJQANCHMSA-N 7-[(8ar)-3,4,6,7,8,8a-hexahydro-1h-pyrrolo[1,2-a]pyrazin-2-yl]-3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound C1CN2CCC[C@@H]2CN1C(C=C1C(=O)O2)=CC=C1C=C2C1=CN2C=C(C)N=C(C)C2=N1 ULXIJKBDXFJGQW-LJQANCHMSA-N 0.000 claims 1
- CMXCYZPTSSHEJE-NRFANRHFSA-N 7-[(8as)-3,4,6,7,8,8a-hexahydro-1h-pyrrolo[1,2-a]pyrazin-2-yl]-3-(1,3-dimethylpyrrolo[1,2-a]pyrazin-7-yl)isochromen-1-one Chemical compound C1CN2CCC[C@H]2CN1C(C=C1C(=O)O2)=CC=C1C=C2C1=CN2C=C(C)N=C(C)C2=C1 CMXCYZPTSSHEJE-NRFANRHFSA-N 0.000 claims 1
- ULXIJKBDXFJGQW-IBGZPJMESA-N 7-[(8as)-3,4,6,7,8,8a-hexahydro-1h-pyrrolo[1,2-a]pyrazin-2-yl]-3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound C1CN2CCC[C@H]2CN1C(C=C1C(=O)O2)=CC=C1C=C2C1=CN2C=C(C)N=C(C)C2=N1 ULXIJKBDXFJGQW-IBGZPJMESA-N 0.000 claims 1
- OXNYVUNBAIZZDG-UHFFFAOYSA-N 7-[4-(dimethylamino)piperidin-1-yl]-3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)isochromen-1-one Chemical compound C1CC(N(C)C)CCN1C1=CC=C(C=C(OC2=O)C=3N=C4C(C)=NC(C)=CN4C=3)C2=C1 OXNYVUNBAIZZDG-UHFFFAOYSA-N 0.000 claims 1
- MVQCAJCURNVZAM-UHFFFAOYSA-N 7-piperazin-1-yl-3-pyridin-2-ylisochromen-1-one Chemical compound C1=C2C(=O)OC(C=3N=CC=CC=3)=CC2=CC=C1N1CCNCC1 MVQCAJCURNVZAM-UHFFFAOYSA-N 0.000 claims 1
- XWQYRLYOWZXQJK-UHFFFAOYSA-N 7-piperazin-1-yl-3-thiophen-3-ylisochromen-1-one Chemical compound C1=C2C(=O)OC(C3=CSC=C3)=CC2=CC=C1N1CCNCC1 XWQYRLYOWZXQJK-UHFFFAOYSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims 1
- 241001024304 Mino Species 0.000 claims 1
- 101150015954 SMN2 gene Proteins 0.000 claims 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 claims 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 claims 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 125000005100 aryl amino carbonyl group Chemical group 0.000 claims 1
- 125000001769 aryl amino group Chemical group 0.000 claims 1
- 150000001805 chlorine compounds Chemical group 0.000 claims 1
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 1
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000012458 free base Substances 0.000 claims 1
- 125000006517 heterocyclyl carbonyl group Chemical group 0.000 claims 1
- 125000005844 heterocyclyloxy group Chemical group 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261591102P | 2012-01-26 | 2012-01-26 | |
| US61/591,102 | 2012-01-26 | ||
| PCT/US2013/023067 WO2013112788A1 (en) | 2012-01-26 | 2013-01-25 | Compounds for treating spinal muscular atrophy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017083760A Division JP2017171667A (ja) | 2012-01-26 | 2017-04-20 | 脊髄性筋萎縮症を治療するための化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015511224A JP2015511224A (ja) | 2015-04-16 |
| JP2015511224A5 true JP2015511224A5 (enExample) | 2016-03-03 |
| JP6193888B2 JP6193888B2 (ja) | 2017-09-06 |
Family
ID=48873933
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014554840A Active JP6193888B2 (ja) | 2012-01-26 | 2013-01-25 | 脊髄性筋萎縮症を治療するための化合物 |
| JP2017083760A Pending JP2017171667A (ja) | 2012-01-26 | 2017-04-20 | 脊髄性筋萎縮症を治療するための化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017083760A Pending JP2017171667A (ja) | 2012-01-26 | 2017-04-20 | 脊髄性筋萎縮症を治療するための化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9399649B2 (enExample) |
| EP (1) | EP2809322B9 (enExample) |
| JP (2) | JP6193888B2 (enExample) |
| KR (1) | KR102064624B1 (enExample) |
| CN (1) | CN104203239B (enExample) |
| BR (1) | BR112014018027B1 (enExample) |
| CA (1) | CA2862084C (enExample) |
| EA (1) | EA028344B1 (enExample) |
| ES (1) | ES2733644T3 (enExample) |
| MX (1) | MX357834B (enExample) |
| PL (1) | PL2809322T3 (enExample) |
| WO (1) | WO2013112788A1 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE47689E1 (en) | 2011-12-30 | 2019-11-05 | Ptc Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
| PL2809322T3 (pl) * | 2012-01-26 | 2019-11-29 | Ptc Therapeutics Inc | Związki do leczenia zaniku mięśni pochodzenia rdzeniowego |
| CN119528903A (zh) | 2012-02-10 | 2025-02-28 | Ptc医疗公司 | 用于治疗脊髓性肌萎缩的化合物 |
| CA2865957C (en) | 2012-03-01 | 2020-02-11 | Ptc Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
| KR102109992B1 (ko) | 2012-03-23 | 2020-05-13 | 피티씨 테라퓨틱스, 인크. | 척수성 근위축증을 치료하기 위한 화합물 |
| US10987370B2 (en) * | 2012-12-24 | 2021-04-27 | Ramot At Tel-Aviv University Ltd. | Methods of inducing read-through of a nonsense mutation associated with ataxia telangiectasia, Rett syndrome or spinal muscular atrophy by erythromycin or azithromycin |
| BR112015032718A2 (pt) | 2013-08-19 | 2019-09-17 | Hoffmann La Roche | composto de modificação de splicing do gene foxm1, uso do composto, formulação farmacêutica e métodos de triagem de compostos |
| WO2015095446A1 (en) * | 2013-12-19 | 2015-06-25 | Ptc Therapeutics, Inc. | Methods for modulating the amount of rna transcripts |
| WO2015105657A1 (en) | 2013-12-19 | 2015-07-16 | Ptc Therapeutics, Inc. | Methods for modulating the amount of rna transcripts |
| PL3663296T3 (pl) * | 2014-05-15 | 2023-08-07 | F. Hoffmann-La Roche Ag | Sposób wytwarzania związków użytecznych w leczeniu rdzeniowego zaniku mięśni |
| US10882868B2 (en) | 2014-05-15 | 2021-01-05 | Hoffmann-La Roche Inc. | Compounds for treating spinal muscular atrophy |
| US10668171B2 (en) | 2015-05-30 | 2020-06-02 | Ptc Therapeutics, Inc. | Methods for modulating RNA splicing |
| CN108289959B (zh) | 2015-11-12 | 2021-07-16 | 豪夫迈·罗氏有限公司 | 用于治疗脊髓性肌萎缩的组合物 |
| WO2017087486A1 (en) | 2015-11-16 | 2017-05-26 | Ohio State Innovation Foundation | Methods and compositions for treating disorders and diseases using survival motor neuron (smn) protein |
| EP3386978B1 (en) | 2015-12-10 | 2021-01-27 | H. Hoffnabb-La Roche Ag | Bridged piperidine derivatives |
| EA201800367A1 (ru) | 2015-12-10 | 2019-02-28 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Способы лечения болезни хантингтона |
| JP6738044B2 (ja) * | 2016-07-22 | 2020-08-12 | Jnc株式会社 | ベンゾピラン骨格を有する液晶性化合物、液晶組成物、および液晶表示素子 |
| US11702646B2 (en) | 2016-11-28 | 2023-07-18 | Ptc Therapeutics, Inc. | Methods for modulating RNA splicing |
| KR20200033249A (ko) | 2017-06-05 | 2020-03-27 | 피티씨 테라퓨틱스, 인크. | 헌팅턴병 치료 화합물 |
| JP2020523365A (ja) | 2017-06-14 | 2020-08-06 | ピーティーシー セラピューティクス，インコーポレーテッド | Ｒｎａスプライシングを改変する方法 |
| US11395822B2 (en) | 2017-06-28 | 2022-07-26 | Ptc Therapeutics, Inc. | Methods for treating Huntington's disease |
| CA3067591A1 (en) | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | Methods for treating huntington's disease |
| CN111499615B (zh) | 2017-08-04 | 2024-02-02 | 斯基霍克疗法公司 | 用于调节剪接的方法和组合物 |
| US12103926B2 (en) | 2018-03-27 | 2024-10-01 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
| EP3814360B8 (en) | 2018-06-27 | 2024-11-06 | PTC Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
| BR112020026545A2 (pt) | 2018-06-27 | 2021-03-23 | Ptc Therapeutics, Inc. | Compostos heterocíclicos e de heteroarila para o tratamento da doença de huntington |
| EA202092899A1 (ru) | 2018-06-27 | 2021-05-14 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Гетероарильные соединения для лечения болезни гентингтона |
| SG11202013088YA (en) | 2018-06-27 | 2021-02-25 | Reborna Biosciences Inc | Prophylactic or therapeutic agent for spinal muscular atrophy |
| CN114007613A (zh) | 2019-02-05 | 2022-02-01 | 斯基霍克疗法公司 | 用于调节剪接的方法和组合物 |
| JP7603595B2 (ja) | 2019-02-06 | 2024-12-20 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| US11129829B2 (en) | 2019-06-17 | 2021-09-28 | Skyhawk Therapeutics, Inc. | Methods for modulating splicing |
| AU2024286618A1 (en) * | 2023-06-09 | 2025-10-30 | F. Hoffmann-La Roche Ag | Inducible gene expression system |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5854142B2 (ja) * | 1975-04-16 | 1983-12-02 | 株式会社興人 | イソカルボスチリル誘導体の製造方法 |
| US5089633A (en) * | 1987-04-28 | 1992-02-18 | Georgia Tech Research Corporation | Substituted isocoumarins |
| US6180625B1 (en) | 1998-03-24 | 2001-01-30 | Novo Nordisk A/S | Heterocyclic compounds regulating clotting |
| WO2003005025A1 (en) * | 2001-07-03 | 2003-01-16 | Biovitrum Ab | Methods for identifying compounds modulating the activity of ppar-gamma |
| GB0205281D0 (en) * | 2002-03-06 | 2002-04-17 | Novartis Ag | Organic compounds |
| US20040077529A1 (en) | 2002-06-10 | 2004-04-22 | Per-Fredrik Lehmann | Urotensin II receptor agents |
| PL374598A1 (en) * | 2002-06-28 | 2005-10-31 | Vertex Pharmaceuticals Incorporated | Caspase inhibitors and uses thereof |
| JP2004168707A (ja) * | 2002-11-20 | 2004-06-17 | Bayer Cropscience Ag | イソチアゾリルベンゾオキサジン誘導体および病害防除剤 |
| US9068234B2 (en) | 2003-01-21 | 2015-06-30 | Ptc Therapeutics, Inc. | Methods and agents for screening for compounds capable of modulating gene expression |
| ATE440825T1 (de) | 2003-06-06 | 2009-09-15 | Vertex Pharma | Pyrimidin-derivate zur verwendung als modulatoren von atp-bindende kassette transportern |
| CN101146798A (zh) | 2005-01-21 | 2008-03-19 | 詹森药业有限公司 | 用作雌激素受体调节剂的新的杂环苯并[c]色烯衍生物 |
| KR100781704B1 (ko) * | 2005-04-20 | 2007-12-03 | 에스케이케미칼주식회사 | 피리딘 유도체와 이의 제조방법, 및 이를 포함하는약제조성물 |
| AR059339A1 (es) | 2006-02-09 | 2008-03-26 | Chugai Pharmaceutical Co Ltd | Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene |
| WO2008013997A2 (en) | 2006-07-27 | 2008-01-31 | The Trustees Of Columbia University In The City Of New York | Fluorescent substrates for monoamine transporters as optical false neurotransmitters |
| KR20080091949A (ko) | 2007-04-10 | 2008-10-15 | 에스케이케미칼주식회사 | 락톤형 피리딘 화합물을 포함하는 허혈성 질환의 예방 및치료용 약학조성물 |
| JP5276878B2 (ja) | 2007-09-27 | 2013-08-28 | 富士フイルム株式会社 | ベンゾオキサジノン系化合物の製造方法 |
| WO2009151546A2 (en) | 2008-05-27 | 2009-12-17 | Ptc Therapeutics, Inc. | Methods for treating spinal muscular atrophy |
| US8932818B2 (en) | 2008-08-13 | 2015-01-13 | Ptc Therapeutics, Inc. | Screening assays for compounds that modulate programmed ribosomal frameshifting |
| USRE47689E1 (en) | 2011-12-30 | 2019-11-05 | Ptc Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
| PL2809322T3 (pl) * | 2012-01-26 | 2019-11-29 | Ptc Therapeutics Inc | Związki do leczenia zaniku mięśni pochodzenia rdzeniowego |
| CN119528903A (zh) | 2012-02-10 | 2025-02-28 | Ptc医疗公司 | 用于治疗脊髓性肌萎缩的化合物 |
| CA2865957C (en) | 2012-03-01 | 2020-02-11 | Ptc Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
| KR102109992B1 (ko) | 2012-03-23 | 2020-05-13 | 피티씨 테라퓨틱스, 인크. | 척수성 근위축증을 치료하기 위한 화합물 |
-
2013
- 2013-01-25 PL PL13740919T patent/PL2809322T3/pl unknown
- 2013-01-25 BR BR112014018027-0A patent/BR112014018027B1/pt active IP Right Grant
- 2013-01-25 JP JP2014554840A patent/JP6193888B2/ja active Active
- 2013-01-25 KR KR1020147023617A patent/KR102064624B1/ko active Active
- 2013-01-25 CN CN201380016999.2A patent/CN104203239B/zh active Active
- 2013-01-25 MX MX2014008875A patent/MX357834B/es active IP Right Grant
- 2013-01-25 US US14/373,937 patent/US9399649B2/en active Active
- 2013-01-25 CA CA2862084A patent/CA2862084C/en active Active
- 2013-01-25 ES ES13740919T patent/ES2733644T3/es active Active
- 2013-01-25 EP EP13740919.9A patent/EP2809322B9/en active Active
- 2013-01-25 EA EA201491412A patent/EA028344B1/ru not_active IP Right Cessation
- 2013-01-25 WO PCT/US2013/023067 patent/WO2013112788A1/en not_active Ceased
-
2017
- 2017-04-20 JP JP2017083760A patent/JP2017171667A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015511224A5 (enExample) | ||
| JP2015517988A5 (enExample) | ||
| JP2016504290A5 (enExample) | ||
| JP2015509956A5 (enExample) | ||
| NZ628186A (en) | Compounds for treating spinal muscular atrophy | |
| JP2015508075A5 (enExample) | ||
| JP2016529292A5 (enExample) | ||
| NZ600229A (en) | Triazolopyridines | |
| CY1124680T1 (el) | Παραγωγα 8-[6-[3-(αμινο)προποξυ]-3-πυριδυλο]-1-ισοπροπυλο-ιμιδαζο[4,5-c]κινολιν-2-ονης ως εκλεκτiκοι ρυθμιστες κινασης μεταλλαγμενης αταξιας τελαγγειεκτασιας (atm) για τη θεραπευτικη αγωγη του καρκινου | |
| FI3406609T3 (fi) | Bisyklisiä atsayhdisteitä muskariinireseptorin agonisteina | |
| NZ594322A (en) | Poly (ADP-Ribose) Polymerase (PARP) Inhibitors | |
| RU2014152790A (ru) | Пирролопиразоновые ингибиторы танкиразы | |
| RU2015154676A (ru) | Соединения для лечения спинальной мышечной атрофии | |
| RU2012117796A (ru) | Производные пиразолиндиона как ингибиторы надфн-оксидазы | |
| ATE514699T1 (de) | Substituierte pyrrolopyrazolderivate als kinaseinhibitoren | |
| JP2016530283A5 (enExample) | ||
| JP2017510564A5 (enExample) | ||
| PE20090996A1 (es) | Derivados de pirrolopirimidina como inhibidores de cinasa jak3 | |
| JP2019500352A5 (enExample) | ||
| SE0402735D0 (sv) | Novel compounds | |
| RU2018120330A (ru) | Химерные соединения, осуществляющие нацеливание для протеолиза, и способы их получения и применения | |
| MX343014B (es) | Sales y formas cristalinas de un agente inductor de apoptosis. | |
| WO2016142855A3 (en) | Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors | |
| SMP200900041B (it) | Sali e forme cristalline di 2-metil-2-[4-(3-metil-2-osso-8-chinolin-3-il-2,3-diidro-imidazo[4,5-c]chinolin-1il)-fenil]-propionitrile | |
| PE20130611A1 (es) | Triazolopiridinas sustituidas |